Gryphon Staff Evaluate Federal Grant Funding for the Bioeconomy

Defined as economic activity driven by innovation in the life sciences, the bioeconomy is poised to revolutionize global economies on the scale of the industrial revolution. Seeking to expand domestic biotechnology capabilities, President Joe Biden signed the Executive Order on Advancing Biotechnology and Biomanufacturing Innovation for Sustainable, Safe, and Secure American Bioeconomy in September 2022 which establishes a whole-of-government approach to supporting the bioeconomy. As agencies strive to meet the goals set forth for them in the Executive Order, development of new funding programs for biotechnology and expansion of existing ones is anticipated. As part of a broader study of the US bioeconomy, Gryphon staff undertook an analysis of U.S. grant funding for biotechnology expanding upon methods first reported in Bioeconomy.XYZ in March of 2022. The study was published in Bioeconomy.XYZ, a bioeconomy-focused platform, as a follow up to the original analysis.

  • Download the Dataset | Download
  • CLIENT | U.S. Government
  • GRYPHON STAFF | Dr. Rocco Casagrande and Bryn O’Meara
  • PARTNERS¬†| Battelle and Kathryn Hamilton, MS from Bioeconomy.XYZ
Practice Areas

Biosafety, Biosecurity, and Emerging Technologies